Introduction
Gefapixant citrate is a novel medication used primarily as a cough suppressant. It is designed to reduce chronic cough by targeting specific pathways in the body involved in cough reflexes. It represents a new class of drugs that aims to manage persistent coughing, particularly in conditions where traditional treatments may be insufficient.
Uses
Gefapixant citrate is primarily used for:
- Management of chronic cough, including cough associated with chronic bronchitis or other long-term respiratory conditions.
- Providing relief from severe and persistent cough that is not adequately controlled by standard treatments.
Mechanism of Action
Gefapixant citrate works by selectively inhibiting the P2X3 receptor, which is involved in the cough reflex pathway. By blocking these receptors, gefapixant reduces the sensory nerve signaling that triggers coughing, thereby decreasing the frequency and severity of cough.
How Long Does It Take to Work?
The onset of action for gefapixant citrate can vary among individuals. Typically, patients may begin to notice improvement in cough symptoms within a few days to weeks of starting the medication. Full therapeutic effects may take several weeks to become evident.
Absorption
Gefapixant citrate is absorbed orally after administration. Its bioavailability and peak plasma concentrations are achieved relatively quickly following ingestion, though the exact pharmacokinetic parameters may vary based on individual patient characteristics.
Route of Elimination
Gefapixant citrate is primarily eliminated through metabolic pathways in the liver. The drug and its metabolites are then excreted mainly via the urine. Minimal amounts of gefapixant are excreted unchanged in the urine.
Dosage
Treatment with Gefapixant should be initiated and monitored by physicians experienced in managing patients with chronic cough disorders.Adult patients: One 45 mg tablet orally twice daily with or without food. Patients should be advised that if a missed dose is missed, they should skip it and take the next dose at the regular time.
Use in elderly patients: No dose adjustment of Gefapixant due to age is required and no age-specific differences in the efficacy or safety of Gefapixant has been established. This medicine is essentially excreted by the kidneys. Since older patients are more likely to have impaired renal function, the risk of adverse effects may be higher in these patients. Caution should be exercised at the initial dosing frequency.
Use in the pediatric population: The safety and efficacy of Gefapixant have not been established in patients below 18 years of age.
Obstructive sleep apnea: Gefapixant should not be used in patients with refractory chronic cough or unexplained chronic cough and comorbid obstructive sleep apnoea.
Patients with liver disease: Gefapixant has not been studied in patients with hepatic impairment.
Patients with renal impairment: The recommended dose of Gefapixant in patients with severe impairment (eGFR<30 ml/minute/1.73 m2) renal function on non-dialysis is one 45 mg tablet once daily with or without food. No dose adjustment is required in patients with mild or moderate renal impairment (eGFR >30 ml/minute/1.73 m2). In patients with severe renal impairment (eGFR <30 ml/minute/1.73 m2) renal function not requiring dialysis, the dose of Gefapixant should be adjusted.
Effect on driving ability and on the use of machines: Patient may experience dizziness after using Gefapixant, which may affect the ability to drive and use machines.
The dosage of gefapixant citrate should be tailored to the individual patient and condition being treated. Typical dosages are:
- For chronic cough: Administer the recommended dose of gefapixant citrate once daily, as prescribed by a healthcare provider.
Administration
Gefapixant citrate is administered orally. It is usually provided in the form of tablets. The medication should be taken with or without food, as directed by a healthcare provider. Consistent daily administration is important for optimal efficacy.
Side Effects
Common side effects of gefapixant citrate include:
- Nausea or vomiting.
- Headache.
- Dizziness.
- Fatigue.
Toxicity
Toxicity with gefapixant citrate is rare when used at recommended doses. However, overdose or misuse could potentially lead to more severe adverse effects. Seek medical attention if symptoms of toxicity or overdose occur.
Precautions
Precautions for gefapixant citrate include:
- Monitor for signs of adverse reactions, particularly during the initial phase of treatment.
- Use with caution in patients with hepatic impairment, as the drug is metabolized in the liver.
- Avoid abrupt discontinuation without consulting a healthcare provider.
Interaction
Gefapixant citrate may interact with other medications, particularly those affecting liver metabolism. Inform the healthcare provider of all concurrent medications to avoid potential interactions.
Disease Interaction
Use gefapixant citrate with caution in patients with:
- Hepatic disorders, as liver function may affect drug metabolism.
- Renal impairment, as it may influence drug clearance.
Drug Interaction
Drug interactions with gefapixant citrate may occur with medications that impact liver enzymes or affect the metabolism of the drug. It is important to review all medications being taken with a healthcare provider to minimize interaction risks.
Food Interactions
There are no significant food interactions with gefapixant citrate. It can be taken with or without food. However, maintain a consistent dietary pattern to avoid affecting overall health and medication effectiveness.
Pregnancy Use
Gefapixant citrate should be used during pregnancy only if clearly needed and prescribed by a healthcare provider. The risks and benefits must be carefully evaluated, as there is limited data on the safety of gefapixant during pregnancy.
Lactation Use
It is advisable to consult a healthcare provider before using gefapixant citrate while breastfeeding. The drug's potential effects on the infant are not well-studied, and the decision should be based on a risk-benefit assessment.
Acute Overdose
In the event of an acute overdose, seek immediate medical attention. Overdose symptoms may include exacerbation of side effects or toxicity. Treatment will focus on supportive care and symptomatic management.
Contraindication
Gefapixant citrate is contraindicated in individuals with:
- Known hypersensitivity or allergy to gefapixant or any component of the formulation.
- Severe hepatic impairment, as it may significantly impact drug metabolism.
Use Direction
Follow the prescribed dosage and administration instructions provided by a healthcare provider. Consistent use as directed is important for achieving the best therapeutic outcomes.
Storage Conditions
Store gefapixant citrate in a cool, dry place away from direct sunlight and moisture. Keep the medication in its original container and out of reach of children.
Volume of Distribution
The volume of distribution for gefapixant citrate is not specifically documented but is generally associated with its distribution in the body after oral administration.
Half Life
The half-life of gefapixant citrate varies based on individual patient factors but typically falls within a range that supports its once-daily dosing regimen.
Clearance
Gefapixant citrate is primarily cleared through hepatic metabolism, with metabolites excreted in the urine. The clearance rate may be influenced by liver and kidney function.
